- Home
- FGEN vs WIMI Comparison
FGEN vs WIMI Comparison
Compare FGEN & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- WIMI
- Stock Information
- Founded
- FGEN 1993
- WIMI 2015
- Country
- FGEN United States
- WIMI China
- Employees
- FGEN N/A
- WIMI N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- WIMI Computer Software: Prepackaged Software
- Sector
- FGEN Health Care
- WIMI Technology
- Exchange
- FGEN Nasdaq
- WIMI Nasdaq
- Market Cap
- FGEN 38.4M
- WIMI 32.4M
- IPO Year
- FGEN 2014
- WIMI 2020
- Fundamental
- Price
- FGEN $10.56
- WIMI $3.61
- Analyst Decision
- FGEN Strong Buy
- WIMI
- Analyst Count
- FGEN 2
- WIMI 0
- Target Price
- FGEN $146.50
- WIMI N/A
- AVG Volume (30 Days)
- FGEN 66.4K
- WIMI 323.8K
- Earning Date
- FGEN 08-11-2025
- WIMI 01-01-0001
- Dividend Yield
- FGEN N/A
- WIMI N/A
- EPS Growth
- FGEN N/A
- WIMI N/A
- EPS
- FGEN N/A
- WIMI 1.00
- Revenue
- FGEN $7,346,000.00
- WIMI $74,245,408.00
- Revenue This Year
- FGEN N/A
- WIMI N/A
- Revenue Next Year
- FGEN N/A
- WIMI N/A
- P/E Ratio
- FGEN N/A
- WIMI $3.78
- Revenue Growth
- FGEN N/A
- WIMI N/A
- 52 Week Low
- FGEN $4.50
- WIMI $2.24
- 52 Week High
- FGEN $21.94
- WIMI $29.20
- Technical
- Relative Strength Index (RSI)
- FGEN 68.96
- WIMI 48.99
- Support Level
- FGEN $9.05
- WIMI $3.71
- Resistance Level
- FGEN $11.71
- WIMI $4.34
- Average True Range (ATR)
- FGEN 0.77
- WIMI 0.31
- MACD
- FGEN 0.32
- WIMI -0.01
- Stochastic Oscillator
- FGEN 76.95
- WIMI 37.07
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.